DME Capital Management’s Coya Therapeutics COYA Stock Holding History

DME Capital Management’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.7M	Hold	2,335,540	–	–	0.35%	42
2026 Q1	$9.2M	Buy	2,335,540 +309,600	+15%	+$1.45M	0.29%	40
2025 Q4	$11.8M	Buy	2,025,940 +379,500	+23%	+$2.31M	0.41%	31
2025 Q3	$9.38M	Hold	1,646,440	–	–	0.37%	25
2025 Q2	$9.47M	Hold	1,646,440	–	–	0.41%	24
2025 Q1	$10.7M	Hold	1,646,440	–	–	0.54%	22
2024 Q4	$9.43M	Buy	1,646,440 +372,414	+29%	+$2.54M	0.49%	23
2024 Q3	$8.22M	Hold	1,274,026	–	–	0.34%	27
2024 Q2	$7.72M	Hold	1,274,026	–	–	0.38%	25
2024 Q1	$12.6M	Buy	+1,274,026	New	+$9.98M	0.58%	26

Other funds holding COYA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DME Capital Management's COYA Position: Q2 2026 in Review

DME Capital Management held its Coya Therapeutics (COYA) position steady in Q2 2026 at 2,335,540 shares worth $13.7M. The position accounts for 0.35% of the portfolio, ranked #42.

DME Capital Management first reported a position in COYA in Q1 2024 and has held it in 10 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

DME Capital Management held 2,335,540 shares of Coya Therapeutics worth $13.7M as of Q2 2026.
DME Capital Management left its Coya Therapeutics share count unchanged in Q2 2026.
Coya Therapeutics made up 0.35% of DME Capital Management's portfolio in Q2 2026, its #42 holding.
DME Capital Management first reported a position in Coya Therapeutics in Q1 2024 and has held it in 10 quarters since.
54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on DME Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.